Halotide 750mcg Injection
Marketer
Halsted Pharma Private Limited
Salt Composition
Teriparatide (750mcg)
Overview Halotide 750mcg Injection
Parathyroid hormone analog, Halotide 750mcg Injection, treats severe osteoporosis and fracture risk in men and postmenopausal women. Its mechanism involves stimulating bone growth, thus increasing bone density and reducing spinal fracture likelihood. Administered subcutaneously by a healthcare provider or self-administered under guidance, consistent daily dosing maximizes efficacy. Treatment typically lasts up to two years, but adhere to your physician's prescribed duration regardless of symptom improvement. Refrigerate at 2-8°C. Common side effects include arthralgia, injection site inflammation (pain, swelling, erythema), and lower extremity cramps; report persistent or bothersome effects to your doctor. Prior to commencing treatment, disclose any kidney issues (including stones) to your doctor, as hypercalcemia may occur. Pregnant or lactating individuals should seek medical counsel before use. Your doctor might order bone density scans to track treatment progress.
Primary Ingredients of Halotide 750mcg Injection
The provided text is "undefined," which contains no information to rephrase. Therefore, no rewritten text can be provided.
Uses of Halotide 750mcg Injection
Bone fragility
Major Benefits of Halotide 750mcg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Halotide 750mcg Injection:
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Halotide 750mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Halotide 750mcg Injection works:
Parathyroid hormone (PTH) is mimicked by the synthetic injectable medication Halotide 750mcg. Its mechanism involves stimulating osteoblast proliferation and activity, leading to enhanced bone strength and reduced fracture incidence.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol while receiving Halotide 750mcg Injection requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Halotide 750mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Halotide 750mcg Injection with breastfeeding are lacking. Seek medical advice from your physician.
DrivingUNSAFE
Administration of 750mcg Halotide Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Halotide 750mcg Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised. Halotide 750mcg Injection is contraindicated in individuals with severely compromised kidney function.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Halotide 750mcg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Halotide 750mcg Injection :
Should you forget a Halotide 750mcg Injection, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Halotide 750mcg Injection
| Label | Value |
|---|---|
| Chemical Type | Parathyroid Hormone-related Medications |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
3,018 People bought this recently